Abstract
The acetylator phenotypes were determined by means of a sulfamethazine test in 101 Saudi Arabian patients with authenticated coronary atheroma; 65 were found to be slow acetylators. This distribution of phenotypes is not significantly different from that in 220 controls, 148 of whom were slow acetylators. This finding makes it unlikely that compounds containing a primary aromatic amino or a hydrazino group are involved in the aetiology or pathogenesis of coronary atheroma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Evans D. A. N-acetyltransferase. Pharmacol Ther. 1989;42(2):157–234. doi: 10.1016/0163-7258(89)90036-3. [DOI] [PubMed] [Google Scholar]
- Evans D. A., Paterson S., Francisco P., Alvarez G. The acetylator phenotypes of Saudi Arabian diabetics. J Med Genet. 1985 Dec;22(6):479–483. doi: 10.1136/jmg.22.6.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Islam S. I. Polymorphic acetylation of sulphamethazine in rural bedouin and urban-dwellers in Saudi Arabia. Xenobiotica. 1982 May;12(5):323–328. doi: 10.3109/00498258209052472. [DOI] [PubMed] [Google Scholar]